content

Gilead Sciences, Inc. Announces EMA Validation of Marketing Authorization Application for Investigational Chronic

Gilead Sciences, Inc announced that the companyโ€™s Marketing Authorization Application for the investigational, once-daily, single tablet regimen of sofosbuvir 400 mg. ...

Takeda Recognized as one of the Global 100 Most Sustainable Corporationsย for second consecutive year

Takeda Pharmaceutical Company Limited ,is proud to be named by Corporate Knights to the 2017 Global 100 Most Sustainable Corporations in the World Index....

PharmAthene and Altimmune Announce Merger to Create Immunotherapeutics Company Targeting Infectious Diseases

PharmAthene, Inc. and Altimmune, Inc., a privately-held immunotherapeutics company targeting infectious diseases, announced the signing of a definitive agreement for the merger of PharmAthene...

Evotec enters into an integrated drug discovery collaboration with Asahi Kasei Pharma

Evotec AG announced it has entered into an integrated drug discovery collaboration on an ion channel target with Asahi Kasei Pharma Corporation, a wholly...

New UK primary care clinical trials company Interface Clinical Research to offer a more effective model

New clinical trials company, Interface Clinical Research, outlined a new model for running primary care clinical trials at their launch yesterday at the Royal...

MRC Technology, Cancer Research UK and Cancer Research Technology collaborate to focus on cancer immunotherapies

Cancer Research UK, Cancer Research Technology and MRC Technology are joining forces to identify and validate novel drug discovery targets that could lead to...

Fresenius Medical Care Announces Leadership Change in North America

Fresenius Medical Care, the worldโ€™s largest provider of dialysis products and services, today announced a leadership change in North America. William...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read